Related Experiment Video
Updated: Aug 30, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Anti-SARS-CoV-2 Seropositivity Among Children With Newly Diagnosed Type 1 Diabetes Mellitus: A Case-Control Study
Vivien Herczeg1, Andrea Luczay1, Nikolett Ténai1
1Department of Pediatrics, Semmelweis University, Hungary.
Insights
During Hungary's third COVID-19 wave, more children were diagnosed with type 1 diabetes mellitus (T1DM). Newly diagnosed T1DM children showed higher anti-SARS-CoV-2 rates, suggesting a potential link needing further study.
Area of Science:
- Pediatrics
- Endocrinology
- Infectious Diseases
Background:
- Type 1 diabetes mellitus (T1DM) is an autoimmune condition affecting children.
- The COVID-19 pandemic has been linked to various health complications.
- An increase in pediatric T1DM diagnoses was observed during the third COVID-19 wave in Hungary.
Purpose of the Study:
- To investigate the association between SARS-CoV-2 infection and new-onset type 1 diabetes mellitus in children.
- To compare the prevalence of anti-SARS-CoV-2 antibodies in newly diagnosed T1DM children versus those with established T1DM.
Main Methods:
- Retrospective analysis of pediatric patients diagnosed with T1DM during the third COVID-19 wave.
- Testing for anti-SARS-CoV-2 antibodies in newly diagnosed and prevalent T1DM pediatric cohorts.
- Statistical comparison of antibody positivity rates between the two groups.
Main Results:
- A significant increase in new-onset T1DM cases was observed in children during the study period.
- Newly diagnosed T1DM patients exhibited a significantly higher rate of anti-SARS-CoV-2 positivity (OR 3.74, P=0.04).
- Prevalent T1DM children had a lower rate of anti-SARS-CoV-2 positivity.
Conclusions:
- SARS-CoV-2 infection may be associated with an increased risk of developing type 1 diabetes mellitus in children.
- Further research is warranted to elucidate the mechanisms underlying the relationship between COVID-19 and T1DM.
- The findings highlight a potential public health concern regarding viral infections and pediatric diabetes incidence.
Abstract:
A sudden increase in the number of children with newly diagnosed type 1 diabetes mellitus (T1DM) was experienced during the third wave of COVID-19 epidemic in Hungary. The newly diagnosed T1DM patients had a significantly higher rate of anti-SARS-CoV-2 positivity as compared to prevalent T1DM children [OR (95% CI) 3.74 (1,08,13.55); P=0.04]. The relationship between SARS-CoV-2 infection and diabetes needs to be investigated further.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

